Article
Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced Sensitivity.
Biomolecules - 17 Jun 2025
Chan Wei Yen, Stewart Ashleigh, Diefenbach Russell J, Gray Elin S, Lee Jenny H, Scolyer Richard A, Long Georgina V, Rizos Helen
Abstract excerpt
Circulating tumour DNA (ctDNA) is a promising biomarker for personalised oncology. However, its clinical utility is limited by detection sensitivity, particularly in early-stage disease. T-Oligo Primed Polymerase Chain Reaction (TOP-PCR) is a commercial amplification approach utilising an efficient "half-adapter" ligation design and a single-primer-based PCR strategy. This study evaluated the clinical value and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
